ÂÜÀòÂÒÂ×

Sally Hed Dahlquist holds a Master of Business Administration (MBA) from Cardinal Stritch University and a Bachelor of Science (BS) in Genetics and Cell Biology from the University of Minnesota. With extensive experience in the biotech sector, Sally has served as a Biotech Entrepreneur and President & Owner of ImmunoChemistry Technologies, LLC since March 2016, providing consulting services and strategic oversight while transitioning to retirement. Previously, from 1996 to 2016, Sally was the Owner & Vice President of Marketing & Operations at the same company, where responsibilities included corporate finance, strategic marketing, and quality system implementation. Additionally, from 1992 to 1996, Sally worked as a Laboratory Associate in Assay Development at R&D Systems, focusing on ELISA assays and product development research.